Terms: = Kidney tumors AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911
60 results:
1. SGLT2 inhibition and three urological cancers: Up-to-date results.
Lin L; Ning K; Xiang L; Peng L; Li X
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3797. PubMed ID: 38523292
[TBL] [Abstract] [Full Text] [Related]
2. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
Almutairi F; Xu B
Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
[TBL] [Abstract] [Full Text] [Related]
3. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
4. Is chest imaging needed as part of pT1a renal cell carcinoma surveillance after surgical resection?
Charles D; Fitzgerald J; Landowski T; Cooper B; Yong R; Everett R; See W; Jacobsohn K; Johnson S; Langenstroer P
Urol Oncol; 2024 Jan; 42(1):23.e1-23.e4. PubMed ID: 38040536
[TBL] [Abstract] [Full Text] [Related]
5. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities.
Liu S; Sun H; Yang S; Liang N; Gao Y; Qu S; Chen H
J Endocrinol Invest; 2024 May; 47(5):1119-1128. PubMed ID: 37906371
[TBL] [Abstract] [Full Text] [Related]
6. Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma.
Park J; Lee EH; Sim H; Na AY; Choi SY; Chung JW; Ha YS; Kwon TG; Lee S; Lee JN
Cancer Genomics Proteomics; 2023; 20(6):592-601. PubMed ID: 37889066
[TBL] [Abstract] [Full Text] [Related]
7. The Application of CT Radiomics in the Diagnosis of Vein Wall Invasion in Patients With Renal Cell Carcinoma Combined With Tumor Thrombus.
Zhao X; Yan Y; Xie W; Zhao L; Zhang S; Liu J; Liu C; Ma L
Oncologist; 2024 Feb; 29(2):151-158. PubMed ID: 37672362
[TBL] [Abstract] [Full Text] [Related]
8. kidney Function and Risk of Renal Cell Carcinoma.
Alcala K; Zahed H; Cortez Cardoso Penha R; Alcala N; Robbins HA; Smith-Byrne K; Martin RM; Muller DC; Brennan P; Johansson M
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1644-1650. PubMed ID: 37668600
[TBL] [Abstract] [Full Text] [Related]
9. Rapamycin and rapalogs for tuberous sclerosis complex.
Sasongko TH; Kademane K; Chai Soon Hou S; Jocelyn TXY; Zabidi-Hussin Z
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011272. PubMed ID: 37432030
[TBL] [Abstract] [Full Text] [Related]
10. Green tea and coffee consumption and risk of kidney cancer in Japanese adults.
Chen Y; Abe SK; Inoue M; Yamaji T; Iwasaki M; Nomura S; Hashizume M; Tsugane S; Sawada N;
Sci Rep; 2022 Nov; 12(1):20274. PubMed ID: 36434069
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate.
Lone Z; Benidir T; Rainey M; Nair M; Davicioni E; Gibb EA; Williamson S; Gupta S; Chaim Ornstein M; Tendulkar R; Weight C; Nguyen JK; Klein EA; Mian OY
Eur Urol Focus; 2022 Nov; 8(6):1575-1582. PubMed ID: 35662504
[TBL] [Abstract] [Full Text] [Related]
12. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
Meng K; Li Z; Cui X
J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
[TBL] [Abstract] [Full Text] [Related]
13. Genetic Analysis Reveals the Important Role of the
Lai YC; Wang WC
Anticancer Res; 2021 Sep; 41(9):4295-4304. PubMed ID: 34475049
[TBL] [Abstract] [Full Text] [Related]
14. Two-pore physiologically based pharmacokinetic model validation using whole-body biodistribution of trastuzumab and different-size fragments in mice.
Li Z; Li Y; Chang HP; Yu X; Shah DK
J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):743-762. PubMed ID: 34146191
[TBL] [Abstract] [Full Text] [Related]
15. Retroperitoneoscopic partial nephrectomy using a 980/1470-nm dual-diode laser for small exophytic renal tumors.
Dong J; Xu W; Liu G; Xie Y; Qiao Y; Ji Z
Lasers Med Sci; 2022 Feb; 37(1):471-477. PubMed ID: 33713255
[TBL] [Abstract] [Full Text] [Related]
16. Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~.
Tsutsumi T; Komura K; Hashimoto T; Muraoka R; Satake N; Matsunaga T; Tsujino T; Yoshikawa Y; Takai T; Minami K; Taniguchi K; Tanaka T; Uehara H; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Ohno Y; Azuma H
BMC Cancer; 2021 Feb; 21(1):201. PubMed ID: 33639880
[TBL] [Abstract] [Full Text] [Related]
17. Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis.
Pecoraro A; Knipper S; Palumbo C; Rosiello G; Luzzago S; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
J Surg Oncol; 2020 Dec; 122(7):1506-1513. PubMed ID: 32812284
[TBL] [Abstract] [Full Text] [Related]
18. Replacing sedentary time with physical activity and sleep: associations with quality of life in kidney cancer survivors.
Tabaczynski A; Courneya KS; Trinh L
Cancer Causes Control; 2020 Jul; 31(7):669-681. PubMed ID: 32394230
[TBL] [Abstract] [Full Text] [Related]
19. Orthopaedic vs. Neurosurgery - Does a surgeon's specialty have an influence on 90-day complications following surgical intervention of spinal metastases?
Malik AT; Baek J; Alexander JH; Khan SN; Scharschmidt TJ
Clin Neurol Neurosurg; 2020 May; 192():105735. PubMed ID: 32078956
[TBL] [Abstract] [Full Text] [Related]
20. Neurocognitive outcomes in long-term survivors of Wilms tumor: a report from the St. Jude Lifetime Cohort.
Tonning Olsson I; Brinkman TM; Hyun G; Banerjee P; Mulrooney DA; Huang IC; Green DM; Srivastava D; Robison LL; Hudson MM; Krull KR
J Cancer Surviv; 2019 Aug; 13(4):570-579. PubMed ID: 31243647
[TBL] [Abstract] [Full Text] [Related]
[Next]
